John P. Hays, Erasmus MC, on antibiotic resistance targets for point-of-care diagnostics Infectious Disease Hub interviewed John P. Hays due to his DIAGORAS-project paper in Future Microbiology entitled: ‘Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice’. Read the full interview about detecting antibiotic resistance and the hurdles in this field.
The fight against antimicrobial resistance concerns each individual
General practitioners, dentists and emergency room have the power to help prevent misuse and overuse of antibiotics. As they are giving diagnosis and treatment to their patients, they have a role in preventing antibiotic resistance spread. They can join the fight to keep antibiotics working! Antibiotic resistance can affect anyone, of any age, in any country. The DIAGORAS project in … Read More
DIAGORAS participates in a JPIAMR-funded Working Group on Antimicrobial Resistance Rapid Diagnostic Tests (AMR-RDT)
Antimicrobial resistance (AMR) emerged from several factors: overprescriptions, misuse of antibiotics, bacteria’s mutation faster than before reducing the efficacy of the antibiotics currently available. In addition to that, the last review on AMR predicted that if we don’t remediate this growing threat, 10 million people will die each year by 2050[1]. This is the reason why some people and organizations determined to make a … Read More
State-of-the-Art Techniques in the Fight Against Antibiotic Resistance
by John Hays in Parliament magazine, Issue 427 08 February 2016 Dr. John Hays, who takes part in six EU-funded projects – including the DIAGORAS project –, sums up the state-of-the-art techniques currently employed by four EU-funded projects to « generate new scientific knowledge and technological advances » for tackling the antibiotic resistance. The article gives an overview of the … Read More
Combating Antimicrobial Resistance
The 21st of January, a significant step was taken on the important and resonant healthcare subject of Antimicrobial Resistance (AMR): The Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance was launched at the World Economic Forum this day in Davos, Switzerland. The Declaration, written and signed by 85 companies and 9 industrial associations from 18 countries, … Read More